We are very happy to share our latest publication about SARS-CoV-2 neutralizing antibodies!
Congratulations to Michi, Matthias and Christoph, who investigated how somatic hypermutation impacts SARS-CoV-2 neutralizing antibodies. » read more
Congratulations to Michi, Matthias and Christoph, who investigated how somatic hypermutation impacts SARS-CoV-2 neutralizing antibodies. » read more
This study shows that an enhanced SARS-CoV-2 humoral immunity following breakthrough infection builds upon the preexisting memory B cell pool. » read more
This study provides a deep understanding of the mechanisms of HCMV neutralization and identifies promising antibody candidates to prevent and treat HCMV infection. » read more
This study provides knowledge about the dynamics and durability of nAb response in humans which is crucial for the design of future HIV-1 vaccine regimens. » read more
In this study, Christoph and his colleagues provide a framework to determine probabilities of antibody sequence development and show that uninfected and chronically infected individuals have the same chances to develop HIV-1 neutralizing antibodies. » read more
In their study, Christoph and Alexander have discovered antibodies that could lead to a new approach in the treatment of acute and chronic infections with P. aeruginosa » read more
We are happy to announce that our lab is the first on campus to be awarded the highest level of certification (Green) by My Green Lab! » read more
In this study, Felix and his colleagues determined SARS-CoV-2 immunity to assess COVID-19 risk and the need for prevention and mitigation strategies. » read more
Florian is talking about our lab. Check out our new video!
https://vimeo.com/818711869 » read more
In these two studies, published in Cell Host Microbe and Lancet Infectious Diseases, Henning and Kanika analyzed in detail escape of Omicron sublineages (BA.1, BA.1.1, BA.2, BA.2.12.1, BA.4/5, and BA.2.75) both on a polyclonal and monoclonal level. » read more